Cargando…

MMP7 Polymorphisms - A New Tool in Molecular Pathology to Understand Esophageal Cancer

Detalles Bibliográficos
Autores principales:	Bavi, Prashant P., Bu, Rong, Uddin, Shahab, Al-Kuraya, Khawla S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications 2011
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3178915/ https://www.ncbi.nlm.nih.gov/pubmed/21912054 http://dx.doi.org/10.4103/1319-3767.84479

Ejemplares similares

Overexpression of leptin receptor predicts an unfavorable outcome in Middle Eastern ovarian cancer
por: Uddin, Shahab, et al.
Publicado: (2009)

PIK3CA alterations in Middle Eastern ovarian cancers
por: Abubaker, Jehad, et al.
Publicado: (2009)

Phosphorylated IκBα Predicts Poor Prognosis in Activated B-Cell Lymphoma and Its Inhibition with Thymoquinone Induces Apoptosis via ROS Release
por: Hussain, Azhar R., et al.
Publicado: (2013)

Clinico-pathological significance of TNF alpha-induced protein3 (TNFAIP3) in Middle Eastern colorectal carcinoma
por: Bavi, Prashant, et al.
Publicado: (2011)

A very low incidence of BRAF mutations in Middle Eastern colorectal carcinoma
por: Siraj, Abdul K, et al.
Publicado: (2014)

Tissue microarrays for high-throughput molecular pathology
por: Al Kuraya, Khawla, et al.
Publicado: (2004)

Resveratrol Suppresses Constitutive Activation of AKT via Generation of ROS and Induces Apoptosis in Diffuse Large B Cell Lymphoma Cell Lines
por: Hussain, Azhar R., et al.
Publicado: (2011)

Polymorphisms of selected Xenobiotic Genes contribute to the development of Papillary Thyroid Cancer susceptibility in Middle Eastern population
por: Siraj, Abdul K, et al.
Publicado: (2008)

Prognostic significance of TRAIL death receptors in Middle Eastern colorectal carcinomas and their correlation to oncogenic KRAS alterations
por: Bavi, Prashant, et al.
Publicado: (2010)

KRAS and TP53 Mutations in Colorectal Carcinoma
por: Al-Kuraya, Khawla S.
Publicado: (2009)

ALK gene amplification is associated with poor prognosis in colorectal carcinoma
por: Bavi, P, et al.
Publicado: (2013)

MMP7 and MMP8 genetic polymorphisms in bladder cancer patients
por: Wieczorek, Edyta, et al.
Publicado: (2013)

Cross-Talk between NFkB and the PI3-Kinase/AKT Pathway Can Be Targeted in Primary Effusion Lymphoma (PEL) Cell Lines for Efficient Apoptosis
por: Hussain, Azhar R., et al.
Publicado: (2012)

Genetic polymorphisms of MMP1, MMP3 and MMP7 gene promoter and risk of colorectal adenoma
por: Lièvre, Astrid, et al.
Publicado: (2006)

Co-targeting of Cyclooxygenase-2 and FoxM1 is a viable strategy in inducing anticancer effects in colorectal cancer cells
por: Ahmed, Maqbool, et al.
Publicado: (2015)

Differential expression of PD-L1 between primary and metastatic epithelial ovarian cancer and its clinico-pathological correlation
por: Parvathareddy, Sandeep Kumar, et al.
Publicado: (2021)

The selected genetic polymorphisms of metalloproteinases MMP2, 7, 9 and MMP inhibitor TIMP2 in sarcoidosis
por: Piotrowski, Wojciech J., et al.
Publicado: (2011)

Polymorphisms in MMP-1, MMP-2, MMP-7, MMP-13 and MT2A do not contribute to breast, lung and colon cancer risk in polish population
por: Białkowska, Katarzyna, et al.
Publicado: (2020)

Whole Exome-Wide Association Identifies Rare Variants in GALNT9 Associated with Middle Eastern Papillary Thyroid Carcinoma Risk
por: Bu, Rong, et al.
Publicado: (2023)

The study of Lynch syndrome in a special population reveals a strong founder effect and an unusual mutational mechanism in familial adenomatous polyposis
por: Siraj, Abdul K, et al.
Publicado: (2020)

Downregulation of SFRP5 expression and its inverse correlation with those of MMP-7 and MT1-MMP in gastric cancer
por: Zhao, Chenghai, et al.
Publicado: (2009)

Identification of novel BRCA founder mutations in Middle Eastern breast cancer patients using capture and Sanger sequencing analysis
por: Bu, Rong, et al.
Publicado: (2016)

Matrix metalloproteinase (MMP)‐7 in Barrett's esophagus and esophageal adenocarcinoma: expression, metabolism, and functional significance
por: Garalla, Hanan M., et al.
Publicado: (2018)

The roles of MMP8/MMP10 polymorphisms in ischemic stroke susceptibility
por: Zhao, Yong, et al.
Publicado: (2022)

Combined Effects of MMP-7, MMP-8 and MMP-26 on the Risk of Ischemic Stroke
por: Hsieh, Fang-I, et al.
Publicado: (2019)

POLE and POLD1 pathogenic variants in the proofreading domain in papillary thyroid cancer
por: Siraj, Abdul K, et al.
Publicado: (2020)

Identification and characterization of ATM founder mutation in BRCA-negative breast cancer patients of Arab ethnicity
por: Bu, Rong, et al.
Publicado: (2023)

Association of zinc level and polymorphism in MMP-7 gene with prostate cancer in Polish population
por: Białkowska, Katarzyna, et al.
Publicado: (2018)

MED12 is recurrently mutated in Middle Eastern colorectal cancer
por: Siraj, Abdul K, et al.
Publicado: (2018)

APOBEC SBS13 Mutational Signature—A Novel Predictor of Radioactive Iodine Refractory Papillary Thyroid Carcinoma
por: Siraj, Sarah, et al.
Publicado: (2022)

Association of Maternal and Fetal Single-Nucleotide Polymorphisms in Metalloproteinase (MMP1, MMP2, MMP3, and MMP9) Genes with Preeclampsia
por: Sakowicz, Agata, et al.
Publicado: (2018)

The Role of Matrix Metalloproteinases (MMP-8, MMP-9, MMP-13) in Periodontal and Peri-Implant Pathological Processes
por: Luchian, Ionut, et al.
Publicado: (2022)

The polymorphisms of the MMP-1 and the MMP-3 genes and the risk of pelvic organ prolapse
por: Skorupski, Paweł, et al.
Publicado: (2012)

Association of MMP-2 and MMP-9 Polymorphisms with Diabetes and Pathogenesis of Diabetic Complications
por: Gajewska, Beata, et al.
Publicado: (2022)

Role of functional single nucleotide polymorphisms of MMP1, MMP2, and MMP9 in open angle glaucomas
por: Mossböck, Georg, et al.
Publicado: (2010)

Meta-Analysis of MMP2, MMP3, and MMP9 Promoter Polymorphisms and Head and Neck Cancer Risk
por: Zhang, Caiyun, et al.
Publicado: (2013)

The MMP-1, MMP-2, and MMP-9 gene polymorphisms and susceptibility to bladder cancer: a meta-analysis
por: Yan, Yulan, et al.
Publicado: (2014)

XIAP over-expression is an independent poor prognostic marker in Middle Eastern breast cancer and can be targeted to induce efficient apoptosis
por: Hussain, Azhar R., et al.
Publicado: (2017)

Prevalence of germline TP53 mutation among early onset middle eastern breast cancer patients
por: Siraj, Abdul Khalid, et al.
Publicado: (2021)

TPM3 mediates epithelial-mesenchymal transition in esophageal cancer via MMP2/MMP9
por: Chen, Sui, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_o81bpoibaqdrf5q1lk6k7dsdqo